TITLE

Timing of leukocyte filtration during cardiopulmonary bypass

AUTHOR(S)
Matheis, G; Scholz, M; Simon, A; Henrich, D; Wimmer-Greinecker, G; Moritz, A
PUB. DATE
January 2001
SOURCE
Perfusion;Jan2001 Supplement, Vol. 16 Issue 1S, p31
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The effects of leukocyte filtration on the outcome of cardiac surgery with cardiopulmonary bypass (CPB) have been shown by numerous investigators. In the majority of cases a leukocyte filter is placed in the arterial line instead of a standard arterial line filter and used throughout CPB. However, protocols to optimize onset and duration of leukocyte filtration have not been sufficiently evaluated to date. In this paper, current efforts to improve such protocols are demonstrated and discussed. These efforts are based on studies of leukocyte pathogenicity during cardiac surgery. A first study (double-blind randomized) was performed in routine coronary artery bypass graft (CABG) patients to evaluate whether short-term leukocyte filtration during reperfusion by release of the aortic crossclamp would reduce reperfusion-associated myocardial damage. Further data compare the efficacy of three different filtration concepts to reduce CPB-and/or reperfusion-associated leukocyte pathogenicity. Clinical endpoints, standard laboratory variables and functional in vitro assays are provided and discussed.
ACCESSION #
54384578

 

Related Articles

  • Poster presentation 2002. Sutton, Steven W.; Patel, Amit N.; SChmidt, Lori A.; Hunley, Eric K.; Yancey, Lloyd W.; Hebeler, Robert F.; Cheung, Edson H.; Henry III, A Carl; Hamman, Baron L.; Wood, Richard E. // Perfusion;Mar2003 Supplement, Vol. 18, p89 

    Focuses on clinical benefits of continuous leukocyte filtration during cardiopulmonary bypass in patients undergoing valvular repair or replacement. Removal of activated neutrophilis during blood cardioplegia filtration; Causes of postoperative complications associated with cardiopulmonary bypass.

  • Erratum.  // Perfusion;May2005, Vol. 20 Issue 3, p182 

    Presents corrections to the articles "Clinical Benefits of Continuous Leukocyte Filtration During Cardiopulmonary Bypass in Patients Undergoing Valvular Repair or Replacement" and "Inflammatory Cytokine Inhibition of Erythropoiesis in Patients Implanted With a Mechanical Circulatory Assist...

  • The inflammatory response to CPB: the role of leukocyte filtration. Asimakopoulos, George // Perfusion;Mar2002 Supplement, Vol. 17 Issue 2S, p7 

    Leukocyte activation is a significant component of the systemic inflammatory response to cardiopulmonary bypass (CPB). Various strategies have been developed aiming to reduce leukocyte activation and its deleterious effects on organ function after cardiac surgery. Leukocyte filtration aims to...

  • What is the Role of Leukocyte Depletion in Cardiac Surgery? Lim, Hou-Kiat; Anderson, James; Leong, Jee-Yoong; Pepe, Salvatore; Salamonsen, Robert F.; Rosenfeldt, Franklin L. // Heart, Lung & Circulation;Aug2007, Vol. 16 Issue 4, p243 

    Leukocytes play an important pathogenic role in ischaemia-reperfusion injury. During cardiopulmonary bypass, leukocyte filters have the potential to remove leukocytes, thereby reducing contact of activated leukocytes with the endothelium of target organs. Improvement in the safety and efficacy...

  • Strategic leukocyte depletion reduces pulmonary microvascular pressure and improves pulmonary status post-cardiopulmonary bypass. Olivencia-Yurvati, AH; Ferrara, CA; Tierney, N; Wallace, N; Mallet, RT // Perfusion;Mar2003 Supplement, Vol. 18, p23 

    Cardiopulmonary bypass (CPB) precipitates inflammation that causes marked pulmonary dysfunction. Leukocyte filtration has been proposed to reduce these deleterious effects. Other studies show an improvement with aprotinin. We proposed that a combination of these two therapies would...

  • Leukocyte filtration in the early reperfusion phase on cardiopulmonary bypass reduces myocardial injury. Matheis, G.; Scholz, M.; Gerber, J.; Abdel-Rahman, U.; Wimmer-Greinecker, G.; Moritz, A. // Perfusion;Jan2001, Vol. 16 Issue 1, p43 

    Improved myocardial protection and cardiopulmonary bypass (CPB) have limited, but not abolished, intraoperative myocardial damage due to surgical reperfusion injury after release of the aortic crossclamp. In this double-blind, randomized study, we evaluated whether short-term leukocyte...

  • Leukocyte Depletion During CPB: Effects on Inflammation and Lung Function. Amorim, CĂ©lio; Malbouisson, Luiz; Silva, Francisco; Fiorelli, Alfredo; Murakami, Caroline; Carmona, Maria // Inflammation;Feb2014, Vol. 37 Issue 1, p196 

    Cardiopulmonary bypass (CPB) is related to inflammatory response and pulmonary dysfunction. The aim of this study was to evaluate the effects of CPB leukocyte filtration on inflammation and lung function after coronary artery bypass grafting (CABG). A prospective randomized study was performed...

  • Timing of leukocyte filtration during cardiopulmonary bypass. Matheis, G.; Scholz, M.; Simon, A.; Henrich, D.; Wimmer-Greinecker, G.; Moritz, A. // Perfusion;Mar2001 Supplement 1, Vol. 16, p31 

    The effects of leukocyte filtration on the outcome of cardiac surgery with cardiopulmonary bypass (CPB) have been shown by numerous investigators. In the majority of cases a leukocyte filter is placed in the arterial line instead of a standard arterial line filter and used throughout CPB....

  • The inflammatory response to CPB: the role of leukocyte filtration. Asimakopoulos, George // Perfusion;May2002 Supplement 1, Vol. 17, p7 

    Examines the role of leukocyte filtration on the inflammatory response to cardiopulmonary bypass (CPB). Reduction of leukocyte activation and deleterious effects on organ function following cardiac surgery; Controversy on the efficacy of CPB in attenuating the effects of inflammatory response;...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics